Valeda PBM
Dry age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults. It affects the macula, the central part of the retina responsible for the sharp, detailed vision needed for activities such as reading and driving. Dry AMD typically progresses through three stages.
Valeda is the FIRST AND ONLY FDA authorized treatment for dry AMD to improve and maintain vision at about 2 years.
How does Valeda PBM work?
Valeda PBM uses a light-based therapy called photobiomodulation (PBM) to help stimulate energy production in the cells of your eyes.
Stages of dry AMD
Dry AMD can get worse without treatment, eventually leading to permanent vision loss.
Early
Presence of small or medium-sized yellow or white spots on the back of one or both eyes.
Intermediate
Presence of many medium-sized spots or a large spot.
Advanced (geographic atrophy)
Eye tissue slowly wears away, which leads to loss of vision.
Just 3 Treatments each week for 3 weeks!
Treatments can fit into your daily life.
Treatments are given here at the office with Dr. Montezuma. It may take up to 10 minutes or less to complete.
Valeda PBM is non-invasive, which means there are no needles; only light us used.
Your pupils are not dilated, and there is no anesthesia. This means you are free to carry on with your daily activities after treatment.